Arrowhead to Present at Upcoming Scientific Conferences
News May 14, 2013
Scheduled conference presentations in May include the following:
15th Annual North American TIDES Conference - Boston, MA, USA, May 12-15, 2013
May 14, 2013 - An oral presentation titled, “Development of DPC Technology for Therapeutic siRNA Delivery,” will be presented by David Lewis, Ph.D., Vice President, Biology;
May 15, 2013 - An oral presentation titled, “Co-injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Small Interfering RNA-Conjugates In Vivo,” will be presented by David B. Rozema, Ph.D., Vice President, Chemistry;
Digestive Disease Week 2013 – Orlando, FL, USA, May 18-21, 2013
May 18, 2013 - A poster presentation titled, “Long duration of effect from an RNAi therapeutic to treat chronic hepatitis B virus infection correlates with persistence of the phosphorylated guide strand,” will be presented by Christine Wooddell, Ph.D., Senior Scientist.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.